Product Information
CEVIMELINE HCL 30 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $0.6871 per EA under NDC 69452031620. Its NADAC has been published 111 times since May 15, 2024.
Strength
30 mg/1
Manufacturer
Bionpharma Inc.NDC
69452031620
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEVIMELINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218290On Market Since
1/17/2024
Pharmacological Classes
Price Statistics
The NADAC for CEVIMELINE HCL 30 MG CAPSULE has been published 111 times since May 15, 2024, and over the history we have for it it has declined 16.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6871 per EA |
|---|---|
| All-time high | $1.0154 (Sep 11, 2024) |
| All-time low | $0.6268 (Nov 20, 2024) |
| 52-week high | $0.7172 |
| 52-week low | $0.6572 |
| Median price | $0.7103 |
| Average price | $0.7531 |
| Largest weekly change | -27.7% (Nov 20, 2024) |
| Weeks tracked | 111 |
| Tracking since | May 15, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEVIMELINE HCL 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEVIMELINE HCL 30 MG CAPSULE, manufactured by Bionpharma Inc., is $0.6871 per EA (NDC 69452031620), effective Jun 24, 2026.
How has the price of CEVIMELINE HCL 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has declined 16.1%. It has been tracked across 111 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for CEVIMELINE HCL 30 MG CAPSULE?
Since May 15, 2024, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has ranged from a low of $0.6268 (Nov 20, 2024) to a high of $1.0154 (Sep 11, 2024), with a median of $0.7103 per EA.
Are there cheaper alternatives to CEVIMELINE HCL 30 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CEVIMELINE HCL 30 MG CAPSULE, but none are currently priced below it.
Who manufactures CEVIMELINE HCL 30 MG CAPSULE?
CEVIMELINE HCL 30 MG CAPSULE (NDC 69452031620) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification